Oramed Pharmaceuticals Inc. (ORMP) Tops Q3 EPS by 19c
Tweet
Share
E-mailGet Alerts ORMP Hot Sheet
Join SI Premium – FREE
Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) reported Q3 EPS of $0.15, $0.19 better than the analyst estimate of ($0.04). Revenue for the quarter came in at $1.18 million.
For earnings history and earnings-related data on Oramed Pharmaceuticals Inc. (ORMP) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- FOMC minutes from July 28-29th meeting
- Trump: nominate Heidi Overton, MD, PhD, as our next FDA commissioner
- BofA Securities Upgrades Moderna (MRNA) to Neutral
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
